Virus Removal by Filtration: Points to Consider - - BioPharm International


Virus Removal by Filtration: Points to Consider

BioPharm International
Volume 19, Issue 10


After regulatory requirements have been addressed, it is time to look at the protein purification process, not only at the current scale but also at the potential manufacturing scale, to ensure that virus filtration is implemented at the best location in the process.

Parvoviruses have a diameter of ~18–26 nm, but a typical monoclonal IgG antibody has a hydrodynamic diameter of ~8–12 nm. To achieve >4 log10 retention of the viruses and >99% recovery of the protein, parvovirus filters are required to have a very narrow pore size distribution. They are, therefore, generally sensitive to the presence of impurities in the feed solution. Thus, optimizing a virus filtration process involves evaluating the effect of a variety of process parameters to arrive at conditions that will ensure a robust, consistent, economical, and scalable operation.6–9

Impact of Location in the Downstream Process Train

Figure 1. Virus filters can be located at various points in a typical protein purification process. Options for locating a virus filtration step are 1) following the low pH inactivation step 2) Following an intermediate column chromatography step and 3) After the final column chromatography step.
Typically, a normal flow virus filtration step can be implemented at any one of several points in a given downstream process. As shown in Figure 1, for a typical monoclonal antibody process, the virus filtration step can conceivably be implemented at three locations in the downstream purification process: following the low-pH inactivation step, following the intermediate chromatographic operation, or following the final chromatography step. Because protein concentration, impurity concentration, and process volumes can vary throughout the downstream process, the actual filtration requirements—including the required filter area—are highly dependent on where in the process the virus filtration step is located.

Impact of Feed Concentration

Figure 2. The effect of protein concentration on filter area needed can be significant. In this case, the optimum concentration is between 8 and 10 g/L. The optimum concentration can vary, depending upon the protein purity and the buffer conditions.
Feed solution concentration can affect the virus filtration process by reducing product throughput. The level of the impact will depend on the interaction between the filter and the components in the solution being filtered. In general, higher protein concentrations reduce the average process flux through the virus filter. The dependence of average process flux on changes in protein concentration is both protein specific and virus-filter specific. The effect of increasing filter capacity and flow at lower product concentrations is offset by an increase in process volume as the product is diluted. The interplay of these two competing effects can often result in an optimum feed concentration that minimizes the required filtration area. Figure 2 shows the impact of the feed concentration on the filtration area needed to process the same quantity of protein in a fixed time.

blog comments powered by Disqus



GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
USP Joins Chinese Pharmacopoeia Commission for Annual Science Meeting
November 20, 2014
Author Guidelines
Source: BioPharm International,
Click here